Dorian Korz

发表

Ductal access for prevention and therapy of mammary tumors.

Zhe Zhang, S. Sukumar, E. Jaffee, 2006, Cancer research.

PLGA nanoparticle formulation of RK-33: an RNA helicase inhibitor against DDX3

V. Raman, Y. Kato, G. Bol, 2015, Cancer Chemotherapy and Pharmacology.

Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.

C. B. Patel, S. Weitzman, S. Sukumar, 2001, Cancer research.

Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast

P. Argani, S. Sukumar, O. Kallioniemi, 2003, Oncogene.

Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer.

Z. Szallasi, S. Sukumar, G. Klus, 2001, International journal of oncology.

Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.

Pedram Argani, Saraswati Sukumar, S. Weitzman, 2004, The American journal of pathology.

A 5' distal palindrome within the mouse mammary tumor virus-long terminal repeat recruits a mammary gland-specific complex and is required for a synergistic response to progesterone plus prolactin.

R. Hovey, J. Trott, H. Fairfield, 2008, Journal of molecular endocrinology.

HOXA5 Regulates Expression of the Progesterone Receptor*

S. Sukumar, K. Zeller, V. Raman, 2000, The Journal of Biological Chemistry.

Targeting DDX 3 with a small molecule inhibitor for lung cancer therapy

Irving, L. Cope, P. Tran, 2015 .

Cyclin E Is a Target of WT1 Transcriptional Repression*

S. Sukumar, A. Friedman, D. Loeb, 2002, The Journal of Biological Chemistry.

Targeting DDX3 with a small molecule inhibitor for lung cancer therapy

L. Cope, P. V. van Diest, P. Tran, 2015, EMBO molecular medicine.

An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation

S. Sukumar, A. Friedman, D. Loeb, 2003, Leukemia.

Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.

S. Weitzman, S. Sukumar, L. Buluwela, 2001, Cancer research.

Cancers Is Associated with Promoter Hypermethylation Loss of Cyclin D 2 Expression in the Majority of Breast Updated

S. Weitzman, S. Sukumar, V. Raman, 2001 .